Literature DB >> 1331108

Site-directed mutational analysis of human tumor necrosis factor-alpha receptor binding site and structure-functional relationship.

X M Zhang1, I Weber, M J Chen.   

Abstract

In order to define the receptor binding site and the structure-functional relationship of tumor necrosis factor (TNF), single amino acid substitutions were made by site-directed mutagenesis at selected residues of human tumor necrosis factor, using a phagemid mutagenesis/expression vector. The recombinant TNF mutants were compared to the wild type TNF in assays using crude bacterial lysates, for protein yield, solubility, subunit trimerization, receptor binding inhibition activity, and in vitro cytotoxic activity. All mutants which did not form cross-linkable trimer also showed little cytotoxic activity or receptor binding inhibition activity, indicating that trimer formation is obligatory for TNF-alpha activity. Most mutations of internal residues yielded no cross-linkable trimer, while most mutations of surface residues yielded cross-linkable trimer. Mutations at surface residues Leu29, Arg31, and Ala35 yielded cross-linkable trimers with good activities, except proline substitutions which may cause conformational changes in the polypeptide chain. This suggested that these residues are near the receptor binding site. Mutations at other strictly conserved internal residues such as Ser60, His78, and Tyr119 form cross-linkable trimer with little activity. These mutations may indirectly affect the receptor binding site by forming trimers with undetectable abnormalities. Mutants of surface residues Tyr87, Ser95, Ser133, and Ser147 affect receptor binding and cytotoxic activity but not trimer formation, suggesting that these residues are involved directly in receptor binding. The fact that residues Arg31, Ala35, Tyr87, Ser95, and Ser147, located on the opposite sides of a monomer, are clustered at the intersubunit grooves of TNF trimer supports the current notion that TNF receptor binding sites are trivalent and are located at the three intersubunit grooves. However, our finding that Ser133, which is outside the groove, can also be involved directly in receptor binding suggested that the receptor binding sites of TNF may not be confined to the intersubunit grooves, but extended to include additional surface residues.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1331108

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Thiolated recombinant human tumor necrosis factor-alpha protects against Plasmodium berghei K173-induced experimental cerebral malaria in mice.

Authors:  N S Postma; R C Hermsen; D J Crommelin; W M Eling; J Zuidema
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

Review 2.  Knowledge-based model building of proteins: concepts and examples.

Authors:  J Bajorath; R Stenkamp; A Aruffo
Journal:  Protein Sci       Date:  1993-11       Impact factor: 6.725

3.  Photochemically enhanced binding of small molecules to the tumor necrosis factor receptor-1 inhibits the binding of TNF-alpha.

Authors:  P H Carter; P A Scherle; J K Muckelbauer; M E Voss; R Q Liu; L A Thompson; A J Tebben; K A Solomon; Y C Lo; Z Li; P Strzemienski; G Yang; N Falahatpisheh; M Xu; Z Wu; N A Farrow; K Ramnarayan; J Wang; D Rideout; V Yalamoori; P Domaille; D J Underwood; J M Trzaskos; S M Friedman; R C Newton; C P Decicco; J A Muckelbauer
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-09       Impact factor: 11.205

4.  Helicobacter pylori and Porphyromonas gingivalis lipopolysaccharides are poorly transferred to recombinant soluble CD14.

Authors:  M D Cunningham; C Seachord; K Ratcliffe; B Bainbridge; A Aruffo; R P Darveau
Journal:  Infect Immun       Date:  1996-09       Impact factor: 3.441

5.  Molecular cloning and characterization of beluga whale (Delphinapterus leucas) interleukin-1beta and tumor necrosis factor-alpha.

Authors:  F Denis; D Archambault
Journal:  Can J Vet Res       Date:  2001-10       Impact factor: 1.310

6.  Three-in-one chromatography-free purification, tag removal, and site-specific modification of recombinant fusion proteins using sortase A and elastin-like polypeptides.

Authors:  Joseph J Bellucci; Miriam Amiram; Jayanta Bhattacharyya; Dewey McCafferty; Ashutosh Chilkoti
Journal:  Angew Chem Int Ed Engl       Date:  2013-02-19       Impact factor: 15.336

7.  Immunochemical termination of self-tolerance.

Authors:  Jan Grünewald; Meng-Lin Tsao; Roshan Perera; Liqun Dong; Frank Niessen; Ben G Wen; Diane M Kubitz; Vaughn V Smider; Wolfram Ruf; Marc Nasoff; Richard A Lerner; Peter G Schultz
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-06       Impact factor: 11.205

8.  Protection from tumor necrosis factor-mediated cytolysis by platelets.

Authors:  C Philippe; B Philippe; B Fouqueray; J Perez; M Lebret; L Baud
Journal:  Am J Pathol       Date:  1993-12       Impact factor: 4.307

9.  The TNF Receptors p55 and p75 Mediate Chemotaxis of PMN Induced by TNFalpha and a TNFalpha 36-62 Peptide.

Authors:  O Rekdal; Z Konopski; J S Svendsen; J O Winberg; T Espevik; B Osterud
Journal:  Mediators Inflamm       Date:  1994       Impact factor: 4.711

10.  Characterization of the complex formed between a potent neutralizing ovine-derived polyclonal anti-TNFα Fab fragment and human TNFα.

Authors:  W Mark Abbott; Melanie Snow; Sonia Eckersley; Jonathan Renshaw; Gareth Davies; Richard A Norman; Peter Ceuppens; Jerry Slootstra; Joris J Benschop; Yoshitomo Hamuro; Jessica E Lee; Peter Newham
Journal:  Biosci Rep       Date:  2013-08-23       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.